Go to main content

Product Details


Indicated for the treatment of catecholamine-refractory hypotension in septic shock in patients over 18 years of age. Catecholamine-refractory hypotension is present when, despite adequate volume therapy and the use of catecholamines, the mean arterial blood pressure cannot be stabilized at values within the target range.

Drug Facts

Active substance: Argipressin | Pharmaceutical form: Concentrate for the preparation of an infusion solution | Strength: 40 I.U./2 ml

Marketing authorisation holder: Orpha-Devel Handels- & Vertriebs GmbH